

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.80241314 |
| 2 | negative T cell selection (GO:0043383) | 7.06759742 |
| 3 | negative thymic T cell selection (GO:0045060) | 6.41744441 |
| 4 | negative regulation of T cell mediated immunity (GO:0002710) | 6.25347563 |
| 5 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.06771633 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.00295222 |
| 7 | regulation of gamma-delta T cell activation (GO:0046643) | 5.85562089 |
| 8 | interferon-gamma production (GO:0032609) | 5.77305736 |
| 9 | regulation of T cell tolerance induction (GO:0002664) | 5.66233405 |
| 10 | thymic T cell selection (GO:0045061) | 5.55059557 |
| 11 | positive regulation of tolerance induction (GO:0002645) | 5.54276128 |
| 12 | positive T cell selection (GO:0043368) | 5.34874524 |
| 13 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.33770194 |
| 14 | positive regulation of humoral immune response (GO:0002922) | 5.33095763 |
| 15 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 5.30025409 |
| 16 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.29793840 |
| 17 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 5.21452651 |
| 18 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.21238574 |
| 19 | signal complex assembly (GO:0007172) | 5.14731331 |
| 20 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 5.12436456 |
| 21 | positive thymic T cell selection (GO:0045059) | 5.06231760 |
| 22 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 5.05623013 |
| 23 | regulation of natural killer cell mediated immunity (GO:0002715) | 5.05623013 |
| 24 | T cell selection (GO:0045058) | 4.98708432 |
| 25 | negative regulation of cell killing (GO:0031342) | 4.85496495 |
| 26 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.85496495 |
| 27 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 4.84826230 |
| 28 | regulation of regulatory T cell differentiation (GO:0045589) | 4.82483845 |
| 29 | cellular response to interleukin-15 (GO:0071350) | 4.81510320 |
| 30 | T cell receptor signaling pathway (GO:0050852) | 4.80498955 |
| 31 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.74122631 |
| 32 | tolerance induction (GO:0002507) | 4.73351641 |
| 33 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.73087774 |
| 34 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.72121791 |
| 35 | regulation of tolerance induction (GO:0002643) | 4.68958613 |
| 36 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.66827212 |
| 37 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.66274336 |
| 38 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 4.61198027 |
| 39 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.53778175 |
| 40 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.44542583 |
| 41 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.42962719 |
| 42 | positive regulation of cell killing (GO:0031343) | 4.42775764 |
| 43 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.37341993 |
| 44 | activated T cell proliferation (GO:0050798) | 4.26981962 |
| 45 | response to interleukin-15 (GO:0070672) | 4.26789516 |
| 46 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.25223511 |
| 47 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.24788840 |
| 48 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 4.20532450 |
| 49 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.18851504 |
| 50 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.17994156 |
| 51 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 4.05249628 |
| 52 | regulation of cell killing (GO:0031341) | 3.97712294 |
| 53 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.96393620 |
| 54 | DNA deamination (GO:0045006) | 3.94708105 |
| 55 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.89522522 |
| 56 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.85994194 |
| 57 | positive regulation of B cell mediated immunity (GO:0002714) | 3.83265104 |
| 58 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.83265104 |
| 59 | leukocyte aggregation (GO:0070486) | 3.76116103 |
| 60 | positive regulation of interleukin-4 production (GO:0032753) | 3.72812575 |
| 61 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.72284560 |
| 62 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.71772588 |
| 63 | lymphocyte chemotaxis (GO:0048247) | 3.71121715 |
| 64 | alpha-beta T cell differentiation (GO:0046632) | 3.69507337 |
| 65 | negative regulation of interleukin-2 production (GO:0032703) | 3.61882952 |
| 66 | lymphocyte migration (GO:0072676) | 3.59154591 |
| 67 | positive regulation of granulocyte differentiation (GO:0030854) | 3.58312684 |
| 68 | cellular response to interleukin-4 (GO:0071353) | 3.56773267 |
| 69 | alpha-beta T cell activation (GO:0046631) | 3.53854778 |
| 70 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.49412288 |
| 71 | mast cell activation (GO:0045576) | 3.48174575 |
| 72 | positive regulation of type 2 immune response (GO:0002830) | 3.46585788 |
| 73 | T cell migration (GO:0072678) | 3.45003283 |
| 74 | positive regulation of T cell cytokine production (GO:0002726) | 3.43348349 |
| 75 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.41432058 |
| 76 | cellular defense response (GO:0006968) | 3.40018825 |
| 77 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.39192993 |
| 78 | T cell differentiation (GO:0030217) | 3.37019926 |
| 79 | regulation of T cell cytokine production (GO:0002724) | 3.34672665 |
| 80 | regulation of interleukin-4 production (GO:0032673) | 3.34396594 |
| 81 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.32659310 |
| 82 | positive regulation of T cell chemotaxis (GO:0010820) | 3.32074100 |
| 83 | regulation of T cell chemotaxis (GO:0010819) | 3.32074100 |
| 84 | positive regulation of T cell mediated immunity (GO:0002711) | 3.29624086 |
| 85 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 3.27556966 |
| 86 | negative regulation of interferon-gamma production (GO:0032689) | 3.22662463 |
| 87 | cytidine metabolic process (GO:0046087) | 3.21725597 |
| 88 | cytidine catabolic process (GO:0006216) | 3.21725597 |
| 89 | cytidine deamination (GO:0009972) | 3.21725597 |
| 90 | regulation of T cell mediated immunity (GO:0002709) | 3.18611741 |
| 91 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.16595008 |
| 92 | regulation of natural killer cell differentiation (GO:0032823) | 3.13898675 |
| 93 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.09881031 |
| 94 | type I interferon signaling pathway (GO:0060337) | 3.07731444 |
| 95 | cellular response to type I interferon (GO:0071357) | 3.07731444 |
| 96 | T cell costimulation (GO:0031295) | 3.06994892 |
| 97 | response to type I interferon (GO:0034340) | 3.05431161 |
| 98 | positive regulation of leukocyte mediated immunity (GO:0002705) | 3.03989139 |
| 99 | lymphocyte costimulation (GO:0031294) | 3.03503655 |
| 100 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.03424550 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 8.35587351 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 7.30210794 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.89599351 |
| 4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.86932096 |
| 5 | RUNX_20019798_ChIP-Seq_JUKART_Human | 4.32245007 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.31818139 |
| 7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 4.05977026 |
| 8 | MYB_26560356_Chip-Seq_TH2_Human | 3.55401353 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.40334784 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.29685119 |
| 11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.22704300 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.11596281 |
| 13 | VDR_22108803_ChIP-Seq_LS180_Human | 3.04571064 |
| 14 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.97039224 |
| 15 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.81423430 |
| 16 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.61668056 |
| 17 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.61253198 |
| 18 | MYB_26560356_Chip-Seq_TH1_Human | 2.54684709 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.43677242 |
| 20 | UTX_26944678_Chip-Seq_JUKART_Human | 2.40210997 |
| 21 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.36233723 |
| 22 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.29148115 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 2.28201864 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.15829053 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.14331741 |
| 26 | MAF_26560356_Chip-Seq_TH2_Human | 2.13515114 |
| 27 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.98106471 |
| 28 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91848575 |
| 29 | GATA3_26560356_Chip-Seq_TH2_Human | 1.91400496 |
| 30 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.67757842 |
| 31 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.66798737 |
| 32 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.49596797 |
| 33 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.46199000 |
| 34 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.45660822 |
| 35 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.43567779 |
| 36 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.37956368 |
| 37 | SPI1_23127762_ChIP-Seq_K562_Human | 1.35651716 |
| 38 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.35373260 |
| 39 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.34805854 |
| 40 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.34191001 |
| 41 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31088265 |
| 42 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.29285002 |
| 43 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.22186427 |
| 44 | MYC_22102868_ChIP-Seq_BL_Human | 1.18607075 |
| 45 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.16189747 |
| 46 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.10566419 |
| 47 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.06442581 |
| 48 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.02902146 |
| 49 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02457700 |
| 50 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02295688 |
| 51 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.02243100 |
| 52 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.01809831 |
| 53 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.00882118 |
| 54 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.00827988 |
| 55 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.00125963 |
| 56 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.98595416 |
| 57 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97036310 |
| 58 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.96545846 |
| 59 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94445874 |
| 60 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93403883 |
| 61 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91010876 |
| 62 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.90343148 |
| 63 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.89381255 |
| 64 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.88684508 |
| 65 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.87880520 |
| 66 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.85173805 |
| 67 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84775846 |
| 68 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.84616807 |
| 69 | GATA3_26560356_Chip-Seq_TH1_Human | 0.83317372 |
| 70 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.82284808 |
| 71 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.81834245 |
| 72 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81025047 |
| 73 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.80274731 |
| 74 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.80256580 |
| 75 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79939428 |
| 76 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.79632086 |
| 77 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.79143100 |
| 78 | P300_27268052_Chip-Seq_Bcells_Human | 0.79102619 |
| 79 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.78775856 |
| 80 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.78684617 |
| 81 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.78145558 |
| 82 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.77220202 |
| 83 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.77088506 |
| 84 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76954097 |
| 85 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.75701733 |
| 86 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.74368040 |
| 87 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.73637186 |
| 88 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.71397014 |
| 89 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.70923737 |
| 90 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.69453806 |
| 91 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.68596539 |
| 92 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.68330995 |
| 93 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.67285962 |
| 94 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.65421078 |
| 95 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.65009765 |
| 96 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.64893046 |
| 97 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.64271532 |
| 98 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.63797169 |
| 99 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.61469096 |
| 100 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.60908717 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.86480681 |
| 2 | MP0003763_abnormal_thymus_physiology | 4.45125260 |
| 3 | MP0005451_abnormal_body_composition | 4.19218103 |
| 4 | MP0002822_catalepsy | 3.96366830 |
| 5 | MP0000685_abnormal_immune_system | 3.57302858 |
| 6 | MP0005000_abnormal_immune_tolerance | 3.35332096 |
| 7 | MP0001800_abnormal_humoral_immune | 3.05611162 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.95032101 |
| 9 | MP0004947_skin_inflammation | 2.90906276 |
| 10 | MP0003300_gastrointestinal_ulcer | 2.89111353 |
| 11 | MP0003436_decreased_susceptibility_to | 2.85990892 |
| 12 | MP0002420_abnormal_adaptive_immunity | 2.82031309 |
| 13 | MP0001790_abnormal_immune_system | 2.80550660 |
| 14 | MP0005387_immune_system_phenotype | 2.80550660 |
| 15 | MP0001819_abnormal_immune_cell | 2.79813820 |
| 16 | MP0003866_abnormal_defecation | 2.69127699 |
| 17 | MP0002723_abnormal_immune_serum | 2.66701266 |
| 18 | MP0009785_altered_susceptibility_to | 2.65430888 |
| 19 | MP0004381_abnormal_hair_follicle | 2.65012847 |
| 20 | MP0005025_abnormal_response_to | 2.53286269 |
| 21 | MP0000703_abnormal_thymus_morphology | 2.52034617 |
| 22 | MP0009333_abnormal_splenocyte_physiolog | 2.50375820 |
| 23 | MP0002452_abnormal_antigen_presenting | 2.38698960 |
| 24 | MP0010155_abnormal_intestine_physiology | 2.37312359 |
| 25 | MP0002398_abnormal_bone_marrow | 2.31637413 |
| 26 | MP0002419_abnormal_innate_immunity | 2.19258737 |
| 27 | MP0005075_abnormal_melanosome_morpholog | 2.10787514 |
| 28 | MP0000716_abnormal_immune_system | 2.07780197 |
| 29 | MP0002405_respiratory_system_inflammati | 1.94179468 |
| 30 | MP0005310_abnormal_salivary_gland | 1.93605225 |
| 31 | MP0002722_abnormal_immune_system | 1.91842134 |
| 32 | MP0000689_abnormal_spleen_morphology | 1.88529857 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.87985398 |
| 34 | MP0001873_stomach_inflammation | 1.84703365 |
| 35 | MP0002148_abnormal_hypersensitivity_rea | 1.84167934 |
| 36 | MP0008961_abnormal_basal_metabolism | 1.73197971 |
| 37 | MP0003724_increased_susceptibility_to | 1.60754784 |
| 38 | MP0002429_abnormal_blood_cell | 1.53482101 |
| 39 | MP0000372_irregular_coat_pigmentation | 1.48637444 |
| 40 | MP0002006_tumorigenesis | 1.42457015 |
| 41 | MP0009764_decreased_sensitivity_to | 1.40299406 |
| 42 | MP0008260_abnormal_autophagy | 1.36022069 |
| 43 | MP0002132_abnormal_respiratory_system | 1.34351415 |
| 44 | MP0009765_abnormal_xenobiotic_induced | 1.29167091 |
| 45 | MP0002163_abnormal_gland_morphology | 1.28671051 |
| 46 | MP0001533_abnormal_skeleton_physiology | 1.27185763 |
| 47 | MP0001348_abnormal_lacrimal_gland | 1.26870804 |
| 48 | MP0000465_gastrointestinal_hemorrhage | 1.23810006 |
| 49 | MP0008469_abnormal_protein_level | 1.20591534 |
| 50 | MP0008995_early_reproductive_senescence | 1.19667280 |
| 51 | MP0002933_joint_inflammation | 1.18374813 |
| 52 | MP0005503_abnormal_tendon_morphology | 1.12773333 |
| 53 | MP0002735_abnormal_chemical_nociception | 1.07515649 |
| 54 | MP0002736_abnormal_nociception_after | 1.05187322 |
| 55 | MP0008872_abnormal_physiological_respon | 1.04793046 |
| 56 | MP0009763_increased_sensitivity_to | 0.99982175 |
| 57 | MP0002166_altered_tumor_susceptibility | 0.97221679 |
| 58 | MP0003646_muscle_fatigue | 0.97180597 |
| 59 | MP0002396_abnormal_hematopoietic_system | 0.95537546 |
| 60 | MP0001851_eye_inflammation | 0.95003749 |
| 61 | MP0002089_abnormal_postnatal_growth/wei | 0.94609696 |
| 62 | MP0003045_fibrosis | 0.94002489 |
| 63 | MP0002277_abnormal_respiratory_mucosa | 0.92135441 |
| 64 | MP0000613_abnormal_salivary_gland | 0.90414014 |
| 65 | MP0003448_altered_tumor_morphology | 0.87040842 |
| 66 | MP0006082_CNS_inflammation | 0.85646787 |
| 67 | MP0002102_abnormal_ear_morphology | 0.84525494 |
| 68 | MP0004859_abnormal_synaptic_plasticity | 0.80025414 |
| 69 | MP0000490_abnormal_crypts_of | 0.79462074 |
| 70 | MP0003137_abnormal_impulse_conducting | 0.78822963 |
| 71 | MP0003786_premature_aging | 0.78699109 |
| 72 | MP0001919_abnormal_reproductive_system | 0.75846643 |
| 73 | MP0006072_abnormal_retinal_apoptosis | 0.75721714 |
| 74 | MP0001663_abnormal_digestive_system | 0.70235559 |
| 75 | MP0003303_peritoneal_inflammation | 0.69497517 |
| 76 | MP0000383_abnormal_hair_follicle | 0.65575454 |
| 77 | MP0009697_abnormal_copulation | 0.64336011 |
| 78 | MP0001968_abnormal_touch/_nociception | 0.64249310 |
| 79 | MP0001346_abnormal_lacrimal_gland | 0.63898944 |
| 80 | MP0003880_abnormal_central_pattern | 0.63801521 |
| 81 | MP0004130_abnormal_muscle_cell | 0.62611555 |
| 82 | MP0002254_reproductive_system_inflammat | 0.61872441 |
| 83 | MP0003638_abnormal_response/metabolism_ | 0.61264536 |
| 84 | MP0005464_abnormal_platelet_physiology | 0.60885010 |
| 85 | MP0002019_abnormal_tumor_incidence | 0.60327562 |
| 86 | MP0002693_abnormal_pancreas_physiology | 0.59737362 |
| 87 | MP0008877_abnormal_DNA_methylation | 0.55547536 |
| 88 | MP0000858_altered_metastatic_potential | 0.54209888 |
| 89 | MP0002009_preneoplasia | 0.52637178 |
| 90 | MP0002998_abnormal_bone_remodeling | 0.51270035 |
| 91 | MP0000477_abnormal_intestine_morphology | 0.48367253 |
| 92 | MP0002136_abnormal_kidney_physiology | 0.48306185 |
| 93 | MP0005379_endocrine/exocrine_gland_phen | 0.47309723 |
| 94 | MP0001664_abnormal_digestion | 0.46154347 |
| 95 | MP0005253_abnormal_eye_physiology | 0.45539477 |
| 96 | MP0005390_skeleton_phenotype | 0.45412166 |
| 97 | MP0002098_abnormal_vibrissa_morphology | 0.44305927 |
| 98 | MP0001501_abnormal_sleep_pattern | 0.40866980 |
| 99 | MP0005535_abnormal_body_temperature | 0.40666747 |
| 100 | MP0009115_abnormal_fat_cell | 0.39609826 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased IgM level (HP:0003496) | 8.10895323 |
| 2 | IgG deficiency (HP:0004315) | 7.16580896 |
| 3 | Optic neuritis (HP:0100653) | 6.24338648 |
| 4 | Retrobulbar optic neuritis (HP:0100654) | 6.24338648 |
| 5 | Encephalitis (HP:0002383) | 5.66649601 |
| 6 | Myositis (HP:0100614) | 5.60627484 |
| 7 | Orchitis (HP:0100796) | 5.58415930 |
| 8 | Keratoconjunctivitis sicca (HP:0001097) | 4.37627052 |
| 9 | Keratoconjunctivitis (HP:0001096) | 4.32185125 |
| 10 | Severe combined immunodeficiency (HP:0004430) | 4.16775939 |
| 11 | Acute hepatic failure (HP:0006554) | 4.05744090 |
| 12 | T lymphocytopenia (HP:0005403) | 4.00646509 |
| 13 | Abnormality of eosinophils (HP:0001879) | 3.77498075 |
| 14 | Hyperlipoproteinemia (HP:0010980) | 3.74284810 |
| 15 | Stenosis of the external auditory canal (HP:0000402) | 3.72862538 |
| 16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.70932119 |
| 17 | Pustule (HP:0200039) | 3.65359180 |
| 18 | Autoimmune hemolytic anemia (HP:0001890) | 3.60025922 |
| 19 | Gastrointestinal infarctions (HP:0005244) | 3.58694238 |
| 20 | Eosinophilia (HP:0001880) | 3.49452940 |
| 21 | Abnormality of T cell number (HP:0011839) | 3.49397868 |
| 22 | Granulocytopenia (HP:0001913) | 3.43859355 |
| 23 | Hypergammaglobulinemia (HP:0010702) | 3.41531149 |
| 24 | Abnormality of T cells (HP:0002843) | 3.35898705 |
| 25 | Gangrene (HP:0100758) | 3.34346690 |
| 26 | Loss of speech (HP:0002371) | 3.34290709 |
| 27 | Meningitis (HP:0001287) | 3.29088640 |
| 28 | Thick nail (HP:0001805) | 3.28231101 |
| 29 | Eczematoid dermatitis (HP:0000976) | 3.27207592 |
| 30 | Combined immunodeficiency (HP:0005387) | 3.25711984 |
| 31 | Keratitis (HP:0000491) | 3.22551210 |
| 32 | Leukocytosis (HP:0001974) | 3.17683233 |
| 33 | Stomatitis (HP:0010280) | 3.14381296 |
| 34 | Hemoptysis (HP:0002105) | 3.10403625 |
| 35 | Congenital stationary night blindness (HP:0007642) | 3.07224847 |
| 36 | Pulmonary infiltrates (HP:0002113) | 3.06621146 |
| 37 | IgM deficiency (HP:0002850) | 3.03059454 |
| 38 | Abnormality of macrophages (HP:0004311) | 2.96075914 |
| 39 | Recurrent bronchitis (HP:0002837) | 2.92179827 |
| 40 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.87615437 |
| 41 | Recurrent cutaneous fungal infections (HP:0011370) | 2.87615437 |
| 42 | Hypoplastic nipples (HP:0002557) | 2.87071385 |
| 43 | Anorexia (HP:0002039) | 2.75362018 |
| 44 | Chronic diarrhea (HP:0002028) | 2.74946660 |
| 45 | Sparse lateral eyebrow (HP:0005338) | 2.74666783 |
| 46 | B lymphocytopenia (HP:0010976) | 2.73736053 |
| 47 | Abnormality of T cell physiology (HP:0011840) | 2.72625764 |
| 48 | Diastasis recti (HP:0001540) | 2.70764394 |
| 49 | Vasculitis (HP:0002633) | 2.68758741 |
| 50 | Anteriorly placed anus (HP:0001545) | 2.67236655 |
| 51 | Choroideremia (HP:0001139) | 2.66479637 |
| 52 | Oligodontia (HP:0000677) | 2.59341622 |
| 53 | IgA deficiency (HP:0002720) | 2.59173999 |
| 54 | Thyroiditis (HP:0100646) | 2.52093950 |
| 55 | Joint swelling (HP:0001386) | 2.51981068 |
| 56 | Verrucae (HP:0200043) | 2.51680834 |
| 57 | Papilloma (HP:0012740) | 2.51680834 |
| 58 | Hypoproteinemia (HP:0003075) | 2.50577745 |
| 59 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.47368334 |
| 60 | Mediastinal lymphadenopathy (HP:0100721) | 2.46218716 |
| 61 | Pulmonary embolism (HP:0002204) | 2.45124570 |
| 62 | Agammaglobulinemia (HP:0004432) | 2.44333882 |
| 63 | Arterial thrombosis (HP:0004420) | 2.42828199 |
| 64 | Abnormality of B cell number (HP:0010975) | 2.42353655 |
| 65 | Gingivitis (HP:0000230) | 2.41065418 |
| 66 | Recurrent fungal infections (HP:0002841) | 2.41014331 |
| 67 | Cellular immunodeficiency (HP:0005374) | 2.39522057 |
| 68 | Lymphopenia (HP:0001888) | 2.36498127 |
| 69 | Obstructive lung disease (HP:0006536) | 2.34854927 |
| 70 | Chronic obstructive pulmonary disease (HP:0006510) | 2.34854927 |
| 71 | Recurrent abscess formation (HP:0002722) | 2.30246657 |
| 72 | Abnormality of the fingertips (HP:0001211) | 2.27514202 |
| 73 | Conical tooth (HP:0000698) | 2.26283447 |
| 74 | Vertigo (HP:0002321) | 2.25392949 |
| 75 | Breast hypoplasia (HP:0003187) | 2.23734567 |
| 76 | Aplastic anemia (HP:0001915) | 2.23494866 |
| 77 | Erythema (HP:0010783) | 2.18203014 |
| 78 | Xanthomatosis (HP:0000991) | 2.17609090 |
| 79 | Hemorrhage of the eye (HP:0011885) | 2.16591503 |
| 80 | Abnormality of incisor morphology (HP:0011063) | 2.13843431 |
| 81 | Absent hand (HP:0004050) | 2.12988607 |
| 82 | Pancytopenia (HP:0001876) | 2.09255602 |
| 83 | Lymphoma (HP:0002665) | 2.08258223 |
| 84 | Short clavicles (HP:0000894) | 2.06999876 |
| 85 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.05583812 |
| 86 | Supernumerary nipples (HP:0002558) | 2.04971215 |
| 87 | Anomalous pulmonary venous return (HP:0010772) | 1.99125162 |
| 88 | Increased IgE level (HP:0003212) | 1.98673105 |
| 89 | Hypoparathyroidism (HP:0000829) | 1.98511676 |
| 90 | Glomerulopathy (HP:0100820) | 1.92829352 |
| 91 | Abnormality of the pleura (HP:0002103) | 1.91451736 |
| 92 | Aplasia/Hypoplasia of the clavicles (HP:0006710) | 1.87613779 |
| 93 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.86865205 |
| 94 | Acne (HP:0001061) | 1.86193004 |
| 95 | Ridged nail (HP:0001807) | 1.85134229 |
| 96 | Oral leukoplakia (HP:0002745) | 1.81878563 |
| 97 | Chest pain (HP:0100749) | 1.79330782 |
| 98 | Hepatitis (HP:0012115) | 1.78653884 |
| 99 | Spontaneous hematomas (HP:0007420) | 1.74904929 |
| 100 | Skin rash (HP:0000988) | 1.74416214 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 6.17699332 |
| 2 | GRK6 | 4.33179204 |
| 3 | MAP4K1 | 3.86564039 |
| 4 | EPHB1 | 3.40104494 |
| 5 | MAP3K13 | 3.22349488 |
| 6 | PASK | 3.14430987 |
| 7 | KDR | 2.61259174 |
| 8 | TLK1 | 2.53812651 |
| 9 | NEK6 | 2.43789606 |
| 10 | CAMKK2 | 2.26475598 |
| 11 | NLK | 2.25714074 |
| 12 | ITK | 2.24056061 |
| 13 | MAPKAPK3 | 2.23417764 |
| 14 | CLK1 | 2.20988903 |
| 15 | EPHA3 | 2.20770602 |
| 16 | CAMKK1 | 2.12157562 |
| 17 | SIK3 | 2.10085134 |
| 18 | FGFR4 | 1.85043746 |
| 19 | SIK2 | 1.83817490 |
| 20 | TEC | 1.79389828 |
| 21 | BTK | 1.72019512 |
| 22 | TESK2 | 1.66639618 |
| 23 | ACVR1B | 1.65818533 |
| 24 | SYK | 1.61769783 |
| 25 | CSK | 1.61282550 |
| 26 | LCK | 1.47464146 |
| 27 | HCK | 1.35131060 |
| 28 | IKBKB | 1.27949810 |
| 29 | FES | 1.27230488 |
| 30 | MARK3 | 1.25980196 |
| 31 | TAOK1 | 1.25605046 |
| 32 | BCKDK | 1.20227005 |
| 33 | MAP3K11 | 1.18664177 |
| 34 | MAP4K2 | 1.15130110 |
| 35 | NEK9 | 1.14705588 |
| 36 | RIPK4 | 1.11240589 |
| 37 | JAK3 | 1.10779666 |
| 38 | CDK6 | 1.09549612 |
| 39 | IKBKE | 1.07542414 |
| 40 | LYN | 1.07272062 |
| 41 | MAP3K7 | 1.06395815 |
| 42 | TYK2 | 1.01746966 |
| 43 | MAP3K14 | 0.98776390 |
| 44 | NME1 | 0.96350056 |
| 45 | DAPK1 | 0.95291230 |
| 46 | MELK | 0.89469595 |
| 47 | SIK1 | 0.88892316 |
| 48 | ERN1 | 0.87342442 |
| 49 | IRAK1 | 0.87125234 |
| 50 | JAK1 | 0.86879271 |
| 51 | FGFR3 | 0.86391096 |
| 52 | CDK4 | 0.86120047 |
| 53 | PRKCQ | 0.84082804 |
| 54 | ZAP70 | 0.79034466 |
| 55 | ALK | 0.72871977 |
| 56 | PTK2B | 0.71925545 |
| 57 | IRAK4 | 0.70437148 |
| 58 | FYN | 0.66148755 |
| 59 | MAP3K1 | 0.63621189 |
| 60 | JAK2 | 0.63456377 |
| 61 | TAOK3 | 0.56266526 |
| 62 | TNK2 | 0.52666395 |
| 63 | TYRO3 | 0.51951562 |
| 64 | IGF1R | 0.50710015 |
| 65 | MAP3K3 | 0.50438378 |
| 66 | TRPM7 | 0.46518752 |
| 67 | KIT | 0.42926606 |
| 68 | PIM1 | 0.39115613 |
| 69 | KSR2 | 0.39024427 |
| 70 | NUAK1 | 0.36385774 |
| 71 | TAOK2 | 0.35384517 |
| 72 | CDK8 | 0.34298690 |
| 73 | EGFR | 0.34054663 |
| 74 | FGFR2 | 0.33871244 |
| 75 | ERBB3 | 0.31418776 |
| 76 | MAPKAPK2 | 0.30494615 |
| 77 | MAP2K3 | 0.30379495 |
| 78 | TBK1 | 0.28252707 |
| 79 | RAF1 | 0.28154669 |
| 80 | YES1 | 0.27581128 |
| 81 | TESK1 | 0.26096120 |
| 82 | MAPK11 | 0.24713137 |
| 83 | IRAK3 | 0.23209449 |
| 84 | PIK3CG | 0.23205657 |
| 85 | CDK14 | 0.22404037 |
| 86 | BLK | 0.20973089 |
| 87 | ABL1 | 0.20905148 |
| 88 | HIPK2 | 0.20576016 |
| 89 | PRKCD | 0.20177297 |
| 90 | CSF1R | 0.19953618 |
| 91 | NTRK2 | 0.19681964 |
| 92 | GRK7 | 0.19421085 |
| 93 | CDK11A | 0.19316644 |
| 94 | PAK6 | 0.18860321 |
| 95 | MAPK12 | 0.18084364 |
| 96 | FER | 0.16543304 |
| 97 | PRKAA2 | 0.16305438 |
| 98 | MAPK7 | 0.15815330 |
| 99 | CDK15 | 0.14350534 |
| 100 | INSR | 0.11518200 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.45287956 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.72856792 |
| 3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.74647601 |
| 4 | Measles_Homo sapiens_hsa05162 | 2.69695764 |
| 5 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.65758053 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.64603121 |
| 7 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.43707941 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.30045497 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.24627992 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 2.17189718 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.15916333 |
| 12 | Shigellosis_Homo sapiens_hsa05131 | 2.12632577 |
| 13 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 2.10434333 |
| 14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.07466278 |
| 15 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.89362431 |
| 16 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.85740983 |
| 17 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.82332364 |
| 18 | Ribosome_Homo sapiens_hsa03010 | 1.71930699 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.59269745 |
| 20 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.58685552 |
| 21 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.56537218 |
| 22 | RNA polymerase_Homo sapiens_hsa03020 | 1.56050704 |
| 23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.51739445 |
| 24 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.48605286 |
| 25 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.46911860 |
| 26 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.46131501 |
| 27 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.43515213 |
| 28 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.43076613 |
| 29 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.41327946 |
| 30 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.40637822 |
| 31 | Malaria_Homo sapiens_hsa05144 | 1.35672205 |
| 32 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.35524876 |
| 33 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.27263228 |
| 34 | Viral myocarditis_Homo sapiens_hsa05416 | 1.22433806 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.12113335 |
| 36 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.09527881 |
| 37 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.90213680 |
| 38 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.84631287 |
| 39 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.83711160 |
| 40 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.83161900 |
| 41 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.82287390 |
| 42 | Platelet activation_Homo sapiens_hsa04611 | 0.81503242 |
| 43 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.80731451 |
| 44 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.79172705 |
| 45 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.78508932 |
| 46 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.78329250 |
| 47 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.77933440 |
| 48 | Tuberculosis_Homo sapiens_hsa05152 | 0.77036042 |
| 49 | Leishmaniasis_Homo sapiens_hsa05140 | 0.75855208 |
| 50 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.72718325 |
| 51 | Homologous recombination_Homo sapiens_hsa03440 | 0.71856699 |
| 52 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.67934313 |
| 53 | HTLV-I infection_Homo sapiens_hsa05166 | 0.65210058 |
| 54 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.64851831 |
| 55 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.63586609 |
| 56 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.62549103 |
| 57 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.59637409 |
| 58 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.58934675 |
| 59 | Asthma_Homo sapiens_hsa05310 | 0.58121593 |
| 60 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.58072570 |
| 61 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.56088254 |
| 62 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.55810267 |
| 63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.53897034 |
| 64 | Pertussis_Homo sapiens_hsa05133 | 0.50559221 |
| 65 | Hepatitis C_Homo sapiens_hsa05160 | 0.49024331 |
| 66 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.48336577 |
| 67 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.48057848 |
| 68 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.44860154 |
| 69 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44431634 |
| 70 | Endocytosis_Homo sapiens_hsa04144 | 0.43585134 |
| 71 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.42602294 |
| 72 | Hepatitis B_Homo sapiens_hsa05161 | 0.41048344 |
| 73 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.40372140 |
| 74 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38712638 |
| 75 | Proteasome_Homo sapiens_hsa03050 | 0.37781065 |
| 76 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.36236119 |
| 77 | Legionellosis_Homo sapiens_hsa05134 | 0.36178440 |
| 78 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.35928296 |
| 79 | Phototransduction_Homo sapiens_hsa04744 | 0.35919137 |
| 80 | Apoptosis_Homo sapiens_hsa04210 | 0.35316187 |
| 81 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.35220561 |
| 82 | Salmonella infection_Homo sapiens_hsa05132 | 0.34362621 |
| 83 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.34183654 |
| 84 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.29007432 |
| 85 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.28789516 |
| 86 | Influenza A_Homo sapiens_hsa05164 | 0.28651098 |
| 87 | Morphine addiction_Homo sapiens_hsa05032 | 0.27367117 |
| 88 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.27214547 |
| 89 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.26607191 |
| 90 | Olfactory transduction_Homo sapiens_hsa04740 | 0.26526100 |
| 91 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.25462901 |
| 92 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.25225888 |
| 93 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.25180003 |
| 94 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.23184467 |
| 95 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.22846787 |
| 96 | Phagosome_Homo sapiens_hsa04145 | 0.22637096 |
| 97 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.22490422 |
| 98 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.21671953 |
| 99 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.20854053 |
| 100 | Insulin resistance_Homo sapiens_hsa04931 | 0.19951683 |

